Financial instruments (Details Narrative) - USD ($) |
Aug. 04, 2020 |
May 29, 2020 |
May 15, 2020 |
Sep. 30, 2020 |
---|---|---|---|---|
Cash, insured amount | $ 800,000 | |||
Accounts payable and accrued liabilities | 2,400,000 | |||
Notes payable current portion | 500,000 | |||
Proceeds from shares issued | $ 4,680,000 | $ 4,680,000 | ||
Credit Concentration Risk [Member] | ||||
Cash, uninsured amount | $ 13,800,000 | |||
Maximum [Member] | ||||
Sale of offerings as common stocks | $ 100,000,000 | |||
Maximum [Member] | At Market Issuance Sales Agreement [Member] | ||||
Proceeds from shares issued | $ 10,000,000 |
X | ||||||||||
- Definition Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other. No definition available.
|
X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|